X. Zheng

Novel phenolic antioxidants as multifunctional inhibitors of inducible VCAM-1 expression for use in atherosclerosis.

C. Kunsch, S. Parthasarathy, M. Wasserman, 2002, Bioorganic & medicinal chemistry letters.

Inhibition of PAF-induced human platelet aggregation by antithrombotic nipecotomides.

E. O. Dillingham, X. Zheng, R. Gollamudi, 1995, Prostaglandins, leukotrienes, and essential fatty acids.

Discovery of novel heteroaryl-substituted chalcones as inhibitors of TNF-alpha-induced VCAM-1 expression.

J. Gilmore, C. Kunsch, Jason W Skudlarek, 2004, Bioorganic & medicinal chemistry letters.

New carbamoylpiperidines as human platelet aggregation inhibitors.

M. Dugdale, X. Zheng, R. Gollamudi, 2000, Bioorganic & medicinal chemistry.

Synergistic antiplatelet effects of a nipecotamide A-1C and low dose aspirin.

W. H. Lawrence, E. O. Dillingham, X. Zheng, 1994, General pharmacology.

Nitrobenzene compounds inhibit expression of VCAM-1.

U. Saxena, C. Meng, P. K. Somers, 2001, Bioorganic & medicinal chemistry letters.

Design and synthesis of piperidine-3-carboxamides as human platelet aggregation inhibitors.

K. Prasad, E. O. Dillingham, X. Zheng, 1995, Journal of Medicinal Chemistry.

Discovery of novel phenolic antioxidants as inhibitors of vascular cell adhesion molecule-1 expression for use in chronic inflammatory diseases.

C. Kunsch, M. Wasserman, U. Saxena, 2004, Journal of medicinal chemistry.